Mr. Yanay has been Co-Chief Executive Officer of Pluristem Therapeutics Inc. since 2017 and has been its President since 2014. Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, exposure to ...